P2.13-09 Efficacy and Safety of Osimertinib After Prior EGFR TKI: Analysis of Patients Underrepresented in Randomized Clinical Trials

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1404

Related search